Analyst Ratings for Quince Therapeutics Inc. (QNCX)
QNCX Rating Summary
QNCX Price Target Summary
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.00 (-78.8%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$4.00 (-78.8%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/24/2026 | Leerink | Joseph P. Schwartz | New Coverage | Outperform (N/A) |
4.00 (N/A) |
0.97 (18.88) |
1846.39% | Details |
| 6/23/2026 | Cantor Fitzgerald » Updated 6/25/2026 |
Olivia Brayer | New Coverage | Overweight (N/A) |
4.00 (N/A) |
0.93 (18.88) |
1930.11% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
